Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel sst receptor modulators prepared and tested at ChemBridge

Dec. 5, 2003

Ortho-McNeil scientists discover new androgen receptor modulators

Dec. 5, 2003

Protein prenyltransferase inhibitors newly identified at PPD Discovery

Dec. 5, 2003

In vivo efficacy of drugs targeting tumor vasculature

Dec. 4, 2003

Telcyta awarded fast track status for third-line therapy of NSCLC

Dec. 4, 2003

Xcytrin granted fast track status for brain metastases in NSCLC patients

Dec. 4, 2003

Maxim licenses MX-90745 series to Myriad

Dec. 4, 2003

Rolling NDA submission continues for Onco TCS

Dec. 4, 2003

German approval for Leuprogel one-month depot product

Dec. 4, 2003

New inhibitors of ERK2 and other protein kinases covered by Vertex patent

Dec. 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...